Hydroxychloroquine and azithromycin: As a double edge sword for COVID-19?

DOI record: { "DOI": "10.1101/2021.01.16.21249941", "URL": "http://dx.doi.org/10.1101/2021.01.16.21249941", "abstract": "<jats:title>Abstract</jats:title><jats:sec><jats:title>Background</jats:title><jats:p>Hydroxychloroquine with or without azithromycin was one of the common therapies at the beginning of the COVID-19 pandemic. They can prolong QT interval, cause Torsade de pointes, and lead to sudden cardiac death. We aimed to assess QT interval prolongation and its risk factors in patients who received hydroxychloroquine with or without azithromycin.</jats:p></jats:sec><jats:sec><jats:title>Methods</jats:title><jats:p>This was a retrospective cohort study. 172 patients with COVID-19 included, hospitalized at hospitals of Babol University of Medical Sciences between March 5, 2020, and April 3, 2020. Patients were divided into two groups: hydroxychloroquine alone and hydroxychloroquine with azithromycin. Electrocardiograms were used for outcome assessment.</jats:p></jats:sec><jats:sec><jats:title>Results</jats:title><jats:p>83.1% of patients received hydroxychloroquine plus azithromycin vs 16.9% of patients who received only hydroxychloroquine. The mean age of patients was 59.2 ± 15.4. The mean of post-treatment QTc interval in the monotherapy group was shorter than the mean of post-treatment QTc interval in the combination therapy group but it had no significant statistical difference (462.5 ± 43.1 milliseconds vs 464.3 ± 59.1 milliseconds;<jats:italic>P</jats:italic>= 0.488). Generally, 22.1% of patients had a prolonged QTc interval after treatment. Male gender, or baseline QTc ≥ 450 milliseconds, or high-risk Tisdale score increased the likelihood of prolonged QTc interval. Due to QTc prolongation, 14 patients did not continue therapy after 4 days.</jats:p></jats:sec><jats:sec><jats:title>Conclusion</jats:title><jats:p>Hospitalized patients treated with hydroxychloroquine with or without azithromycin, had no significant difference in prolongation of QT interval and outcome. But the number of patients with prolonged QT intervals in this study emphasizes careful cardiac monitoring during therapy; especially in high-risk patients.</jats:p></jats:sec>", "accepted": { "date-parts": [ [ 2021, 1, 26 ] ] }, "author": [ { "affiliation": [], "family": "Eftekhar", "given": "Seyed Parsa", "sequence": "first" }, { "ORCID": "http://orcid.org/0000-0002-8068-5745", "affiliation": [], "authenticated-orcid": false, "family": "Kazemi", "given": "Sohrab", "sequence": "additional" }, { "ORCID": "http://orcid.org/0000-0001-8733-9370", "affiliation": [], "authenticated-orcid": false, "family": "Barary", "given": "Mohammad", "sequence": "additional" }, { "ORCID": "http://orcid.org/0000-0002-2771-4578", "affiliation": [], "authenticated-orcid": false, "family": "Javanian", "given": "Mostafa", "sequence": "additional" }, { "ORCID": "http://orcid.org/0000-0003-3204-0448", "affiliation": [], "authenticated-orcid": false, "family": "Ebrahimpour", "given": "Soheil", "sequence": "additional" }, { "affiliation": [], "family": "Ziaei", "given": "Naghmeh", "sequence": "additional" } ], "container-title": [], "content-domain": { "crossmark-restriction": false, "domain": [] }, "created": { "date-parts": [ [ 2021, 1, 26 ] ], "date-time": "2021-01-26T18:15:15Z", "timestamp": 1611684915000 }, "deposited": { "date-parts": [ [ 2024, 4, 23 ] ], "date-time": "2024-04-23T16:25:54Z", "timestamp": 1713889554000 }, "group-title": "Cardiovascular Medicine", "indexed": { "date-parts": [ [ 2024, 4, 24 ] ], "date-time": "2024-04-24T00:16:50Z", "timestamp": 1713917810935 }, "institution": [ { "name": "medRxiv" } ], "is-referenced-by-count": 1, "issued": { "date-parts": [ [ 2021, 1, 26 ] ] }, "link": [ { "URL": "https://syndication.highwire.org/content/doi/10.1101/2021.01.16.21249941", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking" } ], "member": "246", "original-title": [], "posted": { "date-parts": [ [ 2021, 1, 26 ] ] }, "prefix": "10.1101", "published": { "date-parts": [ [ 2021, 1, 26 ] ] }, "publisher": "Cold Spring Harbor Laboratory", "reference": [ { "DOI": "10.1016/S0140-6736(20)30185-9", "doi-asserted-by": "publisher", "key": "2021012807451014000_2021.01.16.21249941v1.1" }, { "key": "2021012807451014000_2021.01.16.21249941v1.2", "unstructured": "World Health Organization, WHO Coronavirus Disease (COVID-19) Dashboard. Available at https://covid19.who.int/. Accessed August 21, 2020." }, { "DOI": "10.1128/AAC.00483-20", "doi-asserted-by": "crossref", "key": "2021012807451014000_2021.01.16.21249941v1.3", "unstructured": "Li, H. , et al., Updated Approaches against SARS-CoV-2. Antimicrob Agents Chemother, 2020. 64(6)." }, { "DOI": "10.1007/s40475-020-00201-6", "doi-asserted-by": "crossref", "key": "2021012807451014000_2021.01.16.21249941v1.4", "unstructured": "Chen, W.H. , et al., The SARS-CoV-2 Vaccine Pipeline: an Overview. Curr Trop Med Rep, 2020: p. 1–4." }, { "DOI": "10.1056/NEJMoa2001316", "doi-asserted-by": "publisher", "key": "2021012807451014000_2021.01.16.21249941v1.5" }, { "DOI": "10.1093/nsr/nwaa036", "doi-asserted-by": "publisher", "key": "2021012807451014000_2021.01.16.21249941v1.6" }, { "DOI": "10.1038/s41422-020-0282-0", "doi-asserted-by": "publisher", "key": "2021012807451014000_2021.01.16.21249941v1.7" }, { "DOI": "10.1093/cid/ciaa237", "doi-asserted-by": "crossref", "key": "2021012807451014000_2021.01.16.21249941v1.8", "unstructured": "Yao, X. , et al., In Vitro Antiviral Activity and Projection of Optimized Dosing Design of Hydroxychloroquine for the Treatment of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2). Clin Infect Dis, 2020." }, { "DOI": "10.1111/1756-185X.13842", "article-title": "A systematic review of the prophylactic role of chloroquine and hydroxychloroquine in coronavirus disease-19 (COVID-19)", "doi-asserted-by": "crossref", "first-page": "613", "issue": "5", "journal-title": "Int J Rheum Dis", "key": "2021012807451014000_2021.01.16.21249941v1.9", "volume": "23", "year": "2020" }, { "DOI": "10.1136/bmj.m1849", "doi-asserted-by": "publisher", "key": "2021012807451014000_2021.01.16.21249941v1.10" }, { "DOI": "10.1001/jama.2020.8630", "article-title": "Association of Treatment With Hydroxychloroquine or Azithromycin With In-Hospital Mortality in Patients With COVID-19 in New York State", "doi-asserted-by": "crossref", "first-page": "2493", "issue": "24", "journal-title": "Jama", "key": "2021012807451014000_2021.01.16.21249941v1.11", "volume": "323", "year": "2020" }, { "key": "2021012807451014000_2021.01.16.21249941v1.12", "unstructured": "National Institutes of Health, COVID-19 Treatment Guidelines Panel. Coronavirus Disease 2019 (COVID-19) Treatment Guidelines. Available at https://www.covid19treatmentguidelines.nih.gov/. Accessed June 25, 2020." }, { "DOI": "10.1038/s41584-020-0372-x", "article-title": "Mechanisms of action of hydroxychloroquine and chloroquine: implications for rheumatology", "doi-asserted-by": "crossref", "first-page": "155", "issue": "3", "journal-title": "Nature Reviews Rheumatology", "key": "2021012807451014000_2021.01.16.21249941v1.13", "volume": "16", "year": "2020" }, { "DOI": "10.1016/S0140-6736(20)30183-5", "doi-asserted-by": "publisher", "key": "2021012807451014000_2021.01.16.21249941v1.14" }, { "DOI": "10.1056/NEJMoa1003833", "doi-asserted-by": "publisher", "key": "2021012807451014000_2021.01.16.21249941v1.15" }, { "DOI": "10.1016/j.mayocp.2020.03.024", "doi-asserted-by": "publisher", "key": "2021012807451014000_2021.01.16.21249941v1.16" }, { "DOI": "10.1136/heart.89.11.1363", "doi-asserted-by": "publisher", "key": "2021012807451014000_2021.01.16.21249941v1.17" }, { "DOI": "10.7150/ijms.34141", "article-title": "Torsades de pointes and QT prolongation Associations with Antibiotics: A Pharmacovigilance Study of the FDA Adverse Event Reporting System", "doi-asserted-by": "crossref", "first-page": "1018", "issue": "7", "journal-title": "Int J Med Sci", "key": "2021012807451014000_2021.01.16.21249941v1.18", "volume": "16", "year": "2019" }, { "key": "2021012807451014000_2021.01.16.21249941v1.19", "unstructured": "Massachusetts General Hospital, QTc Monitoring Guidance. Available at https://www.massgeneral.org/assets/MGH/pdf/news/coronavirus/QTC-monitoring-guidance.pdf. Accessed April 20, 2020." }, { "DOI": "10.1161/01.CIR.30.1.17", "doi-asserted-by": "publisher", "key": "2021012807451014000_2021.01.16.21249941v1.20" }, { "DOI": "10.1186/1475-2875-8-289", "doi-asserted-by": "publisher", "key": "2021012807451014000_2021.01.16.21249941v1.21" }, { "key": "2021012807451014000_2021.01.16.21249941v1.22", "unstructured": "World Health Organization, The cardiotoxicity of antimalarials. Available at https://www.who.int/malaria/mpac/mpac-mar2017-erg-cardiotoxicity-report-session2.pdf. Accessed July 1, 2020." }, { "DOI": "10.1016/S0002-9343(02)01455-9", "doi-asserted-by": "publisher", "key": "2021012807451014000_2021.01.16.21249941v1.23" }, { "DOI": "10.1053/ajem.2001.25774", "doi-asserted-by": "publisher", "key": "2021012807451014000_2021.01.16.21249941v1.24" }, { "DOI": "10.1046/j.1460-9592.2001.01572.x", "doi-asserted-by": "publisher", "key": "2021012807451014000_2021.01.16.21249941v1.25" }, { "DOI": "10.1111/j.1540-8159.2007.00912.x", "doi-asserted-by": "publisher", "key": "2021012807451014000_2021.01.16.21249941v1.26" }, { "DOI": "10.1161/CIRCEP.115.003560", "doi-asserted-by": "publisher", "key": "2021012807451014000_2021.01.16.21249941v1.27" }, { "DOI": "10.1001/jamacardio.2020.1834", "doi-asserted-by": "crossref", "key": "2021012807451014000_2021.01.16.21249941v1.28", "unstructured": "Mercuro, N.J. , et al., Risk of QT Interval Prolongation Associated With Use of Hydroxychloroquine With or Without Concomitant Azithromycin Among Hospitalized Patients Testing Positive for Coronavirus Disease 2019 (COVID-19). JAMA Cardiology, 2020." }, { "DOI": "10.1161/CIRCEP.120.008662", "doi-asserted-by": "crossref", "key": "2021012807451014000_2021.01.16.21249941v1.29", "unstructured": "Saleh, M. , et al., The Effect of Chloroquine, Hydroxychloroquine and Azithromycin on the Corrected QT Interval in Patients with SARS-CoV-2 Infection. Circulation: Arrhythmia and Electrophysiology, 2020." }, { "DOI": "10.2165/00002018-200124080-00002", "doi-asserted-by": "publisher", "key": "2021012807451014000_2021.01.16.21249941v1.30" }, { "DOI": "10.1113/JP270526", "article-title": "Predicting drug-induced QT prolongation and torsades de pointes", "doi-asserted-by": "crossref", "first-page": "2459", "issue": "9", "journal-title": "J Physiol", "key": "2021012807451014000_2021.01.16.21249941v1.31", "volume": "594", "year": "2016" }, { "DOI": "10.1016/S0735-1097(20)33250-2", "doi-asserted-by": "publisher", "key": "2021012807451014000_2021.01.16.21249941v1.32" } ], "reference-count": 32, "references-count": 32, "relation": { "is-preprint-of": [ { "asserted-by": "subject", "id": "10.1155/2021/6683098", "id-type": "doi" } ] }, "resource": { "primary": { "URL": "http://medrxiv.org/lookup/doi/10.1101/2021.01.16.21249941" } }, "score": 1, "short-title": [], "source": "Crossref", "subject": [], "subtitle": [], "subtype": "preprint", "title": "Hydroxychloroquine and azithromycin: As a double edge sword for COVID-19?", "type": "posted-content" }